Provided by Tiger Trade Technology Pte. Ltd.

Merck

143.79
-0.2100-0.15%
Post-market: 143.51-0.2800-0.19%16:37 EDT
Volume:7.83M
Turnover:1.12B
Market Cap:354.75B
PE:112.97
High:144.15
Open:143.85
Low:142.32
Close:144.00
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:0.90
T/O Rate:0.32%
Dividend:3.36
Dividend Rate:2.34%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.46
PE(LYR):19.75

Loading ...

Is Merck (MRK) A Bargain After FDA Approval For LIPFENDRA And HIV PrEP Expansion?

Simply Wall St.
·
Jul 25

Merck Launches Early Access Initiative for Monthly Oral HIV Prevention Drug Alimatravir

Deep News
·
Jul 24

Aspen Pharmacare: Under Agreement, Co to Receive Technical Package from Msd, Together with Licensing Rights Covering 129 Countries

THOMSON REUTERS
·
Jul 24

Merck Outlines Access Plan for Investigational Monthly HIV Prevention Pill

MT Newswires Live
·
Jul 24

Gilead Sciences Says EMA Recommends Trodelvy-Keytruda Combination for Breast Cancer

MT Newswires Live
·
Jul 24

Merck announces initial access plans for alimatravir

TIPRANKS
·
Jul 24

Merck & Co - Signs Seven Voluntary Licensing Agreements with Generic Manufacturers in Africa and India

THOMSON REUTERS
·
Jul 24

Merck & Co - Royalty-free Agreements Enable Supply of Generic Alimatravir in 129 Lmics

THOMSON REUTERS
·
Jul 24

Merck Licenses Experimental HIV Pill to Generic Makers in 129 Countries

Reuters
·
Jul 24

Merck: Voluntary Licensing Agreements for Alimatravir Cover 129 Countries

THOMSON REUTERS
·
Jul 24

Merck: Plans Initial Alimatravir Supply Pending Regulatory Approval, Generic Manufacturing Ramp-up in Licensed Territories

THOMSON REUTERS
·
Jul 24

Merck: Announces Initial Access Plans for Alimatravir in Low- and Middle Income Countries for Prevention of Hiv-1

THOMSON REUTERS
·
Jul 24

Merck: in Active Discussions with Fiocruz on Alimatravir Availability in Latin America & Brazil

THOMSON REUTERS
·
Jul 24

Gilead’s Trodelvy plus Merck’s Keytruda recommended by CHMP in breast cancer

TIPRANKS
·
Jul 24

Merck & Co. Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24

Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers

MT Newswires Live
·
Jul 23

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Trade Options When Others are Fearful

Dow Jones
·
Jul 22

Gilead, Merck Weekly HIV Pill Keeps Virus Suppressed in Late-stage Trials

Reuters
·
Jul 22

Merck Posts Press Release on Once-weekly Oral HIV Regimen Trial Results

Reuters
·
Jul 21